Antibacterial activity of novel bacterial topoisomerase inhibitors against key veterinary pathogens

被引:0
|
作者
Phelps, Hilary A. [1 ]
Kuhn, Michael [1 ]
Lu, Yanran [2 ]
Vibhute, Sandip [2 ,4 ]
Watts, Jeffrey L. [1 ]
Mitton-Fry, Mark J. [2 ,3 ]
机构
[1] Zoetis, Global Therapeut, Anti Infect Res, 333 Portage St, Kalamazoo, MI 49007 USA
[2] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 West 12th Ave, Columbus, OH 43210 USA
[3] 500 West 12th Ave, Columbus, OH 43210 USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA
关键词
Antagonists & amp; Inhibitors; Mastitis; Staphylococcus; ANTIMICROBIAL RESISTANCE; MASTITIS;
D O I
10.1016/j.vetmic.2023.109840
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Multidrug-resistant bacteria infect companion animals and livestock in addition to their devastating impact on human health. Novel Bacterial Topoisomerase Inhibitors (NBTIs) with excellent activity against Gram-positive bacteria have previously been identified as promising new antibacterial agents. Herein, we evaluate the antibacterial activity of these NBTIs against a variety of important veterinary pathogens and demonstrate outstanding in vitro activity, especially against staphylococci.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
    Reck, Folkert
    Ehmann, David E.
    Dougherty, Thomas J.
    Newmana, Joseph V.
    Hopkins, Sussie
    Stone, Gregory
    Agrawal, Nikunj
    Ciaccio, Paul
    McNulty, John
    Barthlow, Herbert
    O'Donnell, Jennifer
    Goteti, Kosalaram
    Breen, John
    Comita-Prevoir, Janelle
    Cornebise, Mark
    Cronin, Mark
    Eyermann, Charles J.
    Geng, Bolin
    Carr, Greg R.
    Pandarinathan, Lakshmipathi
    Tang, Xuejun
    Cottone, Andrew
    Zhao, Liang
    Bezdenejnih-Snyder, Natascha
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5392 - 5409
  • [42] Discovery, synthesis, and antibacterial activity of novel myrtucommulone analogs as inhibitors of DNA gyrase and topoisomerase IV
    Yang, Hao
    Li, Jian
    Wang, Bo-Lin
    Yang, Xin-Ya
    Zhang, Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 283
  • [43] Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity
    Baumann, Sascha
    Herrmann, Jennifer
    Raju, Ritesh
    Steinmetz, Heinrich
    Mohr, Kathrin I.
    Huettel, Stephan
    Harmrolfs, Kirsten
    Stadler, Marc
    Mueller, Rolf
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (52) : 14605 - 14609
  • [44] New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens
    Durcik, Martina
    Nyerges, Akos
    Skok, Ziga
    Skledar, Darja Gramec
    Trontelj, Jurij
    Zidar, Nace
    Ilas, Janez
    Zega, Anamarija
    Cruz, Cristina D.
    Tammela, Paivi
    Welin, Martin
    Kimbung, Yengo R.
    Focht, Dorota
    Benek, Ondrej
    Revesz, Tamas
    Draskovits, Gabor
    Szili, Petra Eva
    Daruka, Lejla
    Pal, Csaba
    Kikelj, Danijel
    Masic, Lucija Peterlin
    Tomasic, Tihomir
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
  • [45] Antibacterial Activity and Mechanisms of Action of Inorganic Nanoparticles against Foodborne Bacterial Pathogens: A Systematic Review
    Girma, Abayeneh
    Abera, Birhanu
    Mekuye, Bawoke
    Mebratie, Gedefaw
    IET NANOBIOTECHNOLOGY, 2024, 2024 : 5417924
  • [46] Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
    Shankar Thangamani
    Haroon Mohammad
    Mostafa F. N. Abushahba
    Tiago J. P. Sobreira
    Victoria E. Hedrick
    Lake N. Paul
    Mohamed N. Seleem
    Scientific Reports, 6
  • [47] Antibacterial Activity of Essential Oils and Extracts of Some Medicinal Plants against Bacterial Fish Pathogens
    Metin, Secil
    Kara, Nimet
    Didinen, Behire Isil
    Kubilay, Aysegul
    ISRAELI JOURNAL OF AQUACULTURE-BAMIDGEH, 2021, 73
  • [48] The in vitro antibacterial activity of the anthelmintic drug oxyclozanide against common small animal bacterial pathogens
    Levinson, Matthew R.
    Blondeau, JosephM.
    Rosenkrantz, Wayne S.
    Plowgian, Curtis B.
    VETERINARY DERMATOLOGY, 2019, 30 (04) : 314 - +
  • [49] Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
    Thangamani, Shankar
    Mohammad, Haroon
    Abushahba, Mostafa F. N.
    Sobreira, Tiago J. P.
    Hedrick, Victoria E.
    Paul, Lake N.
    Seleem, Mohamed N.
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity
    Reck, Folkert
    Alm, Richard
    Brassil, Patrick
    Newman, Joseph
    DeJonge, Boudewijn
    Eyermann, Charles J.
    Breault, Gloria
    Breen, John
    Comita-Prevoir, Janelle
    Cronin, Mark
    Davis, Hajnalka
    Ehmann, David
    Galullo, Vincent
    Geng, Bolin
    Grebe, Tyler
    Morningstar, Marshall
    Walker, Phil
    Hayter, Barry
    Fisher, Stewart
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7834 - 7847